L707-0955 Screening compound: 1-[2-(4-ethylpiperazin-1-yl)-2-oxoethyl]-7-[(4-methylpiperidin-1-yl)sulfonyl]-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one

L707-0955 Screening compound: 1-[2-(4-ethylpiperazin-1-yl)-2-oxoethyl]-7-[(4-methylpiperidin-1-yl)sulfonyl]-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one
L707-0955 Screening compound: 1-[2-(4-ethylpiperazin-1-yl)-2-oxoethyl]-7-[(4-methylpiperidin-1-yl)sulfonyl]-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one alternative view

Chemical Structure Depiction of ChemDiv screening compound L707-0955
1-[2-(4-ethylpiperazin-1-yl)-2-oxoethyl]-7-[(4-methylpiperidin-1-yl)sulfonyl]-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L707-0955

Molecular Formula

C24H36N4O4S (C24 H36 N4 O4 S)

Compound Name

1-[2-(4-ethylpiperazin-1-yl)-2-oxoethyl]-7-[(4-methylpiperidin-1-yl)sulfonyl]-2,3,4,5-tetrahydro-1H-1-benzazepin-2-one

IUPAC name

1-[2-(4-ethylpiperazin-1-yl)-2-oxoethyl]-7-[(4-methylpiperidin-1-yl)sulfonyl]-2345-tetrahydro-1H-1-benzazepin-2-one

SMILES

CCN(CC1)CCN1C(CN(c(cc1)c(CCC2)cc1S(N1CCC(C)CC1)(=O)=O)C2=O)=O

InChI

InChI=1S/C24H36N4O4S/c1-3-25-13-15-26(16-14-25)24(30)18-28-22-8-7-21(17-20(22)5-4-6-23(28)29)33(31,32)27-11-9-19(2)10-12-27/h7-8,17,19H,3-6,9-16,18H2,1-2H3

InChI Key

BVPFRVCTEAETJH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27472045

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

476.64

Hydrogen Bond Acceptors Count

10.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.226

Distribution Coefficient, logD

2.050

Water Solubility, LogSw

-2.75

Polar Surface Area

67.590

Acid Dissociation Constant (pKa)

22.17

Base Dissociation Constant (pKb)

7.10

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

66.70

L707-0955 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Nonpeptide Peptidomimetics PPI Library (18997 compounds)

Protein-Protein Interaction Library (218420 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
  • Mimetics

References: we are preparing a list of scientific research reports with L707-0955 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L707-0955?
Check Price and Availability of L707-0955, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L707-0955 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L707-0955
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L707-0955
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L707-0955 available by request